Talaporfin sodium

Catalog No. :
ACCTWA974
CAS No. :
220201-34-3
Molecular Formula :
C38H37N5Na4O9
Molecular Weight :
799.70

IUPAC Name:sodium (2-((7S,8S)-3-carboxylato-7-(2-carboxylatoethyl)-18-ethyl-2,8,12,17-tetramethyl-13-vinyl-7H,8H-porphyrin-5-yl)acetyl)-L-aspartate

Talaporfin sodium structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$361.00Login to see priceInquiryInquiry
10mg98%$574.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTalaporfin sodium
IUPAC Namesodium (2-((7S,8S)-3-carboxylato-7-(2-carboxylatoethyl)-18-ethyl-2,8,12,17-tetramethyl-13-vinyl-7H,8H-porphyrin-5-yl)acetyl)-L-aspartate
Molecular FormulaC38H37N5Na4O9
Molecular Weight799.70
SMILESO=C([O-])C[C@@H](C([O-])=O)NC(C/C1=C2[C@@H](CCC([O-])=O)[C@H](C)C(/C=C3C(C)=C(C=C)/C(N/3)=C/C(C(C)=C/4CC)=NC4=C/C5=C(C)C(C([O-])=O)=C1N5)=N\2)=O.[Na+].[Na+].[Na+].[Na+]
InChI KeyKPALSRNVSRWOPA-OBJGRMLXSA-J
SynonymJLWROAPZCOJYGT-OBJGRMLXSA-J | UNII-L63605PZ70 | Aptocine | Talaporfin sodium | Talaporfin tetrasodium salt | LS 11 (photosensitizer) | LS11 | LS-11 | TALAPORFIN TETRASODIUM SALT [MI] | Talaporfinsodium | 4,4'-oxybiphenol | TALAPORFIN SODIUM [WHO-DD] | ME2
CAS No.220201-34-3
PubChem CID5488036

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCTWA974 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCTWA974 route product structure diagram
    ACCTWA974220201-34-3
Inquiry

2. ACCTWA974 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCTWA974 route product structure diagram
    ACCTWA974220201-34-3
Inquiry

Comments (0)